Zhongnan Medical Journal Press

Home Results

A total of 242 result was found. Results that relate to GRA

Construction of a predictive model for asymptomatic venous thromboembolism in patients with ovarian clear cell carcinoma after surgery

Published on New Medicine 2026,36(4):407-413.
1444 times 600 times

REN Hang WANG Hua CAI Hongbing

Ovarian clear cell carcinoma Venous thromboembolism Nomograms Prognosis
Details
Research advances in targeted protein degradation technologies

Published on New Medicine 2026,36(4):464-470.
1769 times 487 times

PI Chuan HAO Xuanrun XIAO Haiting LUO Xing ZHANG Qixiong

Targeted protein degradation Proteolysis targeting chimera Molecular glue Lysosome-targeting chimera Autophagy-targeting chimera Autophagosome-tethering compound
Details
Research advances in metabolic reprogramming-mediated macrophage polarization in gout

Published on New Medicine 2026,36(4):471-478.
1773 times 498 times

LIU Xinru YAN Jin MA Jing LI Chunlei MAN Dafu LI Huilin DA Gula ZHAO Jing WANG Jing LI Hongbin HOU Yunxia WANG Yong

Gout Metabolic reprogramming Macrophage polarization Glycolysis
Details
Exploration and reflection on evidence-based medicine teaching for practical training of research capacity in medical undergraduates under the "five-dimensional" paradigm

Published on New Medicine 2026,36(4):479-486.
2826 times 488 times

LI Zhenxin WU Junru ZHUANG Quan YUAN Hong LU Yao CAI Jingjing

Clinical medicine undergraduates Evidence-based medicine Educational reform Research capability development Teaching model
Details
Mechanism of Gualou Xiebai decoction in treating myocardial infarction based on UPLC-Orbitrap-MS/MS and network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2026,30(4):555-565.
2035 times 525 times

YAN Muxian LAN Yikun ZHOU Yaliang TAN Wanchuang LIN Junjie

Gualou Xiebai decoction Myocardial infarction Network pharmacology Ul-tra-performance liquid chromatography-orbitrap tandem mass spectrometry Mechanism of action Active components Target prediction
Details
Expert consensus for off-label drug use of rare diseases (2026 edition)

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):493-507.
1689 times 490 times

DUAN Yuehan CHEN Chaoyang ZHANG Yu CUI Yi-min WANG Shengfeng DING Jie Working Group of the Expert Consensus for Off-Label Drug Use of Rare Diseases

Rare disease Off-label drug use Expert consensus Thomson evidence grading system
Details
Research on the promotion of clinical practice guidelines implementation (Ⅸ): a framework design for computable formalization of diagnostic and therapeutic process knowledge and construction of knowledge praphs in clinical practice guidelines

Published on New Medicine 2026,36(5):487-494.
680 times 241 times

RUAN Siyuan CHEN Jian TALIFU·Paerwenayi ZHU Shuqiong REN Xiangying YAN Siyu HUANG Qi-ao JIN Yinghui WANG Yongbo

Clinical practice guidelines Diagnostic and therapeutic process Computability Knowledge graph Ontology modeling
Details
Study on the authenticity identification of Fructus Viticis Negundo and the quality transfer law of decoction pieces to standard decoction based on UPLC characteristic chromatogram and multi-index content determination

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):777-786.
845 times 203 times

HE Jiaying WU Wenping LIN Han ZHONG Chunlin SUO Caixian LIU Xiaohan LI Guowei CHEN Xiangdong SUN Dongmei

Fructus Viticis Negundo Vitex Fructus Standard decoction Characteristic chromatogram Content determination Quality and quantity transfer Cluster analysis Partial least squares discriminant analysis
Details
Simultaneous determination of 10 impurities in ibuprofen and its preparations by UPLC method

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):804-812.
877 times 165 times

YUN Xiaofei ZHANG Yanxia QIAN Yujuan HAN Feng XIAO Honghua YAN Zeman WANG Meng

Ibuprofen Ultra-performance liquid chromatography Impurities Toxicity Quality control
Details
Retrospective study on the efficacy of insulin degludec/insulin aspart combined with dietary management in patients with type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):813-819.
856 times 163 times

XIANG Yuyang XIE Yuye LIN Zhihao

Type 2 diabetes mellitus Insulin degludec/insulin aspart Integrated diet management model Efficacy observation
Details
Research progress on multidrug resistance mechanism of non-small cell lung cancer and reversal effect of active ingredients of traditional Chinese medicine

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):857-866.
812 times 149 times

ZHENG Wanrong LAI Fobao

Tumor multidrug resistance Non-small cell lung cancer Active components of traditional Chinese medicine Resistance reversal Non-coding RNA Programmed cell death
Details
Development of a predictive model for the risk of antimicrobial drug-induced thrombocytopenia using 5 machine learning algorithms

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):625-634.
324 times 82 times

WANG Min SHEN Xiaoyan

Machine learning Antimicrobial drugs Thrombocytopenia Prediction model Risk factors Extreme gradient boosting SHapley Additive exPlanation
Details
Efficacy and safety of galcanezumab in the treatment of migraine in adults: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):669-678.
355 times 90 times

HE Xiaodong LI Qin KE Changhu LI Chunlei LIU Huimin

Galcanezumab Migraine Randomized controlled trial Systematic review Meta-analysis
Details
Rosuvastatin-induced ocular myasthenia gravis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):700-704.
361 times 84 times

WEN Chao WANG Min LI Yali WU Panting TAO Xuxia TANG Xiaoxia

Rosuvastatin Statins Ocular myasthenia gravis Adverse drug reaction
Details
Research on living clinical practice guidelines in diabetes mellitus Ⅲ: methodological characteristics analysis of recommendations classification and evidence grading in the Chinese clinical practice guidelines for type 2 diabetes mellitus

Published on New Medicine 2026,36(6):605-610.
179 times 61 times

WU Ajiao CAI Fengyi XIE Chi WANG Shichun WANG Yongbo YAN Siyu HUANG Qiao REN Xiangying JIN Yinghui TANG Jun

Type 2 diabetes mellitus Clinical practice guidelines Evidence grading Grade of recommendation
Details